Company intelligence / Profile preview

Celemics

Seoul, Seoul Special City (Seoul), South Koreacelemics.com ↗

Ownership: Private
Employees: ~43
Development stage: Commercial

Overview

Celemics develops and manufactures advanced NGS-based solutions, including custom target enrichment panels and pre-set panels for inherited diseases, oncology, immunology, pathogen diagnostics, agrigenomics, and more. Their proprietary technologies enable high-quality data generation with optimized workflows for research institutes, hospitals, clinical labs, and biopharma companies worldwide.

Modalities: DeviceReagentBioinformatics pipeline
Industry: Molecular Diagnostics

Partnerships

Not explicitly listed in public sources. The company mentions a "robust global network serving clients and partners in academia, research & clinical diagnostic fields".

Beyond the preview

Go deeper on Celemics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celemics.

Explore the full profile